Murphy Leads Effort to Revive Bipartisan Addiction Treatment Bill

December 4, 2019 by Dan McCue
Murphy Leads Effort to Revive Bipartisan Addiction Treatment Bill

WASHINGTON – Rep. Stephanie Murphy, D-Fla., joined with Reps. Brian Fitzpatrick, R-Pa., and Annie Kuster, D-N.H., to re-introduce the Road to Recovery Act, a bill that would improve addiction treatment options under Medicaid and the Children’s Health Insurance Program.

Specifically, the bipartisan legislation would repeal a federal law — called the “IMD exclusion” — and authorize Medicaid and CHIP to cover treatment at licensed, accredited residential facilities for individuals addicted to opioids and other drugs.

The IMD exclusion is a long-standing policy that prohibits federal Medicaid matching funds to states for services rendered to Medicaid-eligible individuals who are patients for substance use disorder and mental health treatment.

Some states have used an “in lieu of services” provision allowing for inpatient treatment, but with limitations on patient population, facility size, and length of stay. These limitations disproportionately affect Medicaid beneficiaries.

“Opioids have destroyed lives, families and communities throughout central Florida and this country,” Rep. Murphy said.

“Congress must pursue bipartisan solutions to end the opioid epidemic, which is why I’m proud to partner with Reps. Fitzpatrick and Kuster to introduce legislation that will help ensure that men and women addicted to opioids can obtain the high-quality treatment they need and deserve,” she said.

“It is unacceptable that some of our most vulnerable Americans – including children, people with disabilities and those with limited incomes – who are enrolled in Medicaid or CHIP are not able to access the substance use disorder treatment they need,” said Kuster.

“This legislation aims to remove the barriers that are in place and help ensure those who are struggling with addiction have access to the care they need, benefiting the health of our communities and the economic wellbeing of our state.”

Fitzpatrick agreed.

“Pennsylvania has been overwhelmed by the opioid epidemic, and an important part of combatting this epidemic is by ensuring that more Americans can receive life-saving care. Our constituents need treatment for addiction, and they need it now,” he said.

The opioid crisis was responsible for 67,000 overdose deaths in the United States in 2018.

According to the U.S. Department of Health and Human Services, substance abuse costs the country more than $600 billion annually and, based on conservative estimates, each dollar invested in addiction treatment programs yields a return of $4 to $7 in reduced drug-related crime, criminal justice costs, and theft.

A+
a-
  • bipartisan
  • Stephanie Murphy
  • treatment
  • In The News

    Health

    Voting

    Health

    March 27, 2024
    by Dan McCue
    One-Time Treatment Could Revitalize Immune Systems in the Elderly

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of... Read More

    PALO ALTO, Calif. — A new study suggests that a one-time treatment that modulates the composition of a type of immune cell could potentially revitalize the immune systems of the elderly, helping their bodies better react to viral and bacterial threats. The research was carried out... Read More

    March 27, 2024
    by Dan McCue
    Insurers to Expand Access to ‘Navigation Services’ for Cancer Patients

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients... Read More

    WASHINGTON — Seven of the nation’s largest health insurance companies are expanding access to so-called “navigation services” to help patients and their families navigate the myriad challenges that might arise during treatment for cancer and other serious illnesses. The insurers involved are Aetna; Blue Cross Blue... Read More

    Five Takeaways From the Abortion Pill Case Before US Supreme Court

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone,... Read More

    WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It's... Read More

    Biden and Harris Argue Democrats Will Preserve Health Care and Republicans Would Take It Away

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in... Read More

    RALEIGH, N.C. (AP) — President Joe Biden and Vice President Kamala Harris on Tuesday promoted their health care agenda in the battleground state of North Carolina, arguing that Democrats like themselves would preserve access to care while Republicans would reverse gains made over the past decade... Read More

    March 26, 2024
    by Tom Ramstack
    Supreme Court Skeptical of Ban on Abortion Pill Mifepristone

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access... Read More

    WASHINGTON — A hearing Tuesday before the Supreme Court indicated a majority of the justices want to maintain women’s access to the abortion pill mifepristone despite objections from anti-abortion activists. The doctors and organizations who sued argued the Food and Drug Administration was wrong in granting... Read More

    March 26, 2024
    by Dan McCue
    Consumers Warned to Avoid Certain Topical Pain Relief Products 

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed... Read More

    WASHINGTON — The Food and Drug Administration warned consumers on Tuesday not to use certain over-the-counter pain relief products marketed for topical use before, during or after certain cosmetic procedures. The warning came after the agency issued warning letters to six companies for marketing these products... Read More

    News From The Well
    scroll top